Blog

It has been about a month since the last earnings report for Urban Outfitters (URBN). Shares have added about 3.6% in that time frame, outperforming the S&P 500.

Will the recent positive trend

It has been about a month since the last earnings report for V.F. (VFC). Shares have added about 7.1% in that time frame, outperforming the S&P 500.

But investors have to be wondering, will the

It has been about a month since the last earnings report for ZIM Integrated Shipping Services (ZIM). Shares have lost about 3.2% in that time frame, underperforming the S&P 500.

But investors have

It has been about a month since the last earnings report for TJX (TJX). Shares have added about 4% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue leading up

It has been about a month since the last earnings report for Target (TGT). Shares have added about 3.6% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue leading

It has been about a month since the last earnings report for Nvidia (NVDA). Shares have lost about 4% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading

A month has gone by since the last earnings report for Hasbro (HAS). Shares have lost about 5.9% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up

A month has gone by since the last earnings report for Immunovant, Inc. (IMVT). Shares have added about 3.6% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue

It has been about a month since the last earnings report for Intuit (INTU). Shares have lost about 13.1% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will the

It has been about a month since the last earnings report for Lowe's (LOW). Shares have added about 2.2% in that time frame, outperforming the S&P 500.

But investors have to be wondering, will the

A month has gone by since the last earnings report for Golar LNG (GLNG). Shares have lost about 5.2% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will the

A month has gone by since the last earnings report for EnerSys (ENS). Shares have lost about 4.6% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will the recent

A month has gone by since the last earnings report for Analog Devices (ADI). Shares have added about 13.1% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue

Datadog’s DDOG observability consolidation strategy is creating a larger growth opportunity as enterprises work to simplify increasingly complex environments spanning cloud infrastructure

ASE Technology ASX has delivered meaningful margin expansion over the past year, but the bigger question for investors is whether those gains are sustainable. First-quarter 2026 results suggest the

MercadoLibre's MELI aggressive expansion of its first-party (1P) business is emerging as a key headwind to margin recovery. While the strategy is strengthening assortment, improving pricing

Shares of CME Group, Inc. CME have declined 19.8% over the past three months, compared with the industry’s drop of 9.7%, pushing the stock near its 52-week low of $ 244.56. The company’s share price

Astera Labs ALAB is benefiting from robust demand for its Aries and Taurus product lines, which are central to the company’s strong performance in the AI infrastructure market. In the first quarter

Cerebras Systems CBRS is scheduled to report first-quarter 2026 results on June 23.The Zacks Consensus Estimate for first-quarter 2026 earnings is pegged at a loss of 14 cents per share.The Zacks

Shares of Beam Therapeutics BEAM rose 5% on Thursday after the FDA cleared the investigational new drug (IND) application for BEAM-304, the company’s investigational gene-editing therapy for the

Ulta Beauty, Inc. ULTA continues to make progress toward its ambition of becoming the leading destination for fragrance. To support this objective, it is investing in product newness, enhancing the

Regions Financial RF remains focused on rewarding shareholders through dividend payments and share buybacks while pursuing growth opportunities. In July 2025, the company hiked its quarterly

10x Genomics TXG recently entered into a multi-year research collaboration with the Cleveland Clinic to advance novel diagnostic applications for bladder cancer. The study will use the company's

Equinor ASA EQNR presents an updated strategy focused on delivering higher production, stronger cash flows and enhanced shareholder returns through 2030. Equinor plans to increase total production